Molecular mechanism underlying the synergistic interaction between trifluorothymidine and the epidermal growth factor receptor inhibitor erlotinib in human colorectal cancer cell lines

I.V. Bijnsdorp; F.A.E. Kruyt; M Fukushima; K Smid; S. Gokoel; G.J. Peters

doi:https://doi.org/10.1111/j.1349-7006.2009.01375.x

Molecular mechanism underlying the synergistic interaction between trifluorothymidine and the epidermal growth factor receptor inhibitor erlotinib in human colorectal cancer cell lines

I.V. Bijnsdorp, F.A.E. Kruyt, M Fukushima, K Smid, S. Gokoel, G.J. Peters

Research output: Contribution to journal › Article › Academic › peer-review

26 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	440-447
Journal	Cancer science
Volume	101
Issue number	2
DOIs	https://doi.org/10.1111/j.1349-7006.2009.01375.x
Publication status	Published - 2010

Access to Document

https://doi.org/10.1111/j.1349-7006.2009.01375.x

https://research.vumc.nl/ws/files/745868/256305.pdf

Cite this

@article{438f5ea346434dcf9dab9e6cf2929a4b,

title = "Molecular mechanism underlying the synergistic interaction between trifluorothymidine and the epidermal growth factor receptor inhibitor erlotinib in human colorectal cancer cell lines",

author = "I.V. Bijnsdorp and F.A.E. Kruyt and M Fukushima and K Smid and S. Gokoel and G.J. Peters",

year = "2010",

doi = "https://doi.org/10.1111/j.1349-7006.2009.01375.x",

language = "Undefined/Unknown",

volume = "101",

pages = "440--447",

journal = "Cancer science",

issn = "1347-9032",

publisher = "Wiley-Blackwell",

number = "2",

}

Molecular mechanism underlying the synergistic interaction between trifluorothymidine and the epidermal growth factor receptor inhibitor erlotinib in human colorectal cancer cell lines. / Bijnsdorp, I.V.; Kruyt, F.A.E.; Fukushima, M et al.
In: Cancer science, Vol. 101, No. 2, 2010, p. 440-447.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Molecular mechanism underlying the synergistic interaction between trifluorothymidine and the epidermal growth factor receptor inhibitor erlotinib in human colorectal cancer cell lines

AU - Bijnsdorp, I.V.

AU - Kruyt, F.A.E.

AU - Fukushima, M

AU - Smid, K

AU - Gokoel, S.

AU - Peters, G.J.

PY - 2010

Y1 - 2010

U2 - https://doi.org/10.1111/j.1349-7006.2009.01375.x

DO - https://doi.org/10.1111/j.1349-7006.2009.01375.x

M3 - Article

SN - 1347-9032

VL - 101

SP - 440

EP - 447

JO - Cancer science

JF - Cancer science

IS - 2

ER -